PharVision Advisers »

New York Times Company shares owned by PharVision Advisers

Quarter-by-quarter ownership of New York Times Company (NYT) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in New York Times Company

Tip: Access up to 7 years of quarterly data

All positions including New York Times Company held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in New York Times Company by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $361k 6.3k 57.40
2025-03-31 $332k 6.7k 49.60
2024-12-31 $292k 5.6k 52.05

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding New York Times Company

Vanguard Group
BlackRock
T. Rowe Price Investment Management
Darsana Capital Partners
Farallon Capital Management
State Street Corporation
Wellington Management Company
AQR Capital Management
Geode Capital Management
Route One Investment Company
Renaissance Technologies
Baillie Gifford & Co
Dimensional Fund Advisors
Acadian Asset Management
Burgundy Asset Management

View all funds holding New York Times Company